Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
 Posted on February 28, 2025

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen – Endpoints News

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen  Endpoints News
Source: BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen – Endpoints News

By sf-admin

Post navigation

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines – Business Wire
BridgeBio's cancer spinout backs SPAC as path to Nasdaq – Fierce Biotech


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace